Search clinical trials for: Pegylated liposomal doxorubicin
Total 3439 results
-
PfizerTerminatedOvarian Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Aprea TherapeuticsCompletedHigh-grade Serous Ovarian CancerSpain, United Kingdom, Belgium
-
THERAPIM PTY LTDNovotech (Australia) Pty LimitedTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serious or Endometrioid Carcinoma of the Ovary, Fallopian Tube, or Primary Peritoneal CancerAustralia
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Grupo Español de Investigación en Cáncer de OvarioGlaxoSmithKline; Hoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY... and other collaboratorsActive, not recruitingRecurrent Ovarian CarcinomaFrance, Spain, Belgium, Italy, Germany
-
Atreca, Inc.TerminatedMelanoma | Breast Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Acral Lentiginous Melanoma | Platinum-Resistant Fallopian... and other conditionsUnited States
-
University of ArizonaTerminatedBreast CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade... and other conditionsUnited States
-
Sherif Farag, MB, BSHoosier Cancer Research Network; Cephalon, Inc.TerminatedBendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple MyelomaMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedGingivitis | PlaqueUnited States
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
PfizerCompletedOvarian CancerUnited States, Canada, Australia, France, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Austria, Denmark, Hungary, Singapore, Hong Kong, Belgium, Japan, Ireland, Italy, Netherlands, Czechia, Poland, Switzerland, Russian... and more
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI); University College, London; Medical Research...CompletedMetastatic Osteosarcoma | Localized OsteosarcomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchActive, not recruitingRecurrent Ovarian CancerFrance, Italy, Switzerland, Monaco, Greece
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
Spanish Breast Cancer Research GroupSchering-PloughCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Aravive, Inc.CompletedEfficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian CancerOvarian CancerUnited States
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
Masonic Cancer Center, University of MinnesotaCompletedSarcomaUnited States
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
Grupo Español de Investigación en Cáncer de OvarioAstraZeneca; Apices Soluciones S.L.Completed
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
Oslo University HospitalSwedish Orphan BiovitrumCompletedChemotherapy-induced Nausea and Vomiting | Chemotherapy Effect | Chemotherapeutic Toxicity | Ovarian Neoplasm | Chemotherapy-induced Neutropenia
-
Roswell Park Cancer InstituteEisai Inc.CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruiting
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
MedSIRRoche Pharma AG; ExperiorCompleted
-
Hoosier Cancer Research NetworkBoehringer IngelheimTerminated
-
Mario Negri Institute for Pharmacological ResearchPharmaMar; Averion International CorporationCompletedOvarian CancerAustria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
-
TTY BiopharmActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Korea, Republic of, Spain, Taiwan
-
EndocyteTerminated
-
Eisai Inc.CompletedPlatinum-Sensitive Ovarian Cancer in First RelapseUnited States, Italy, United Kingdom, Germany, Spain, Belgium, Japan
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
Astex Pharmaceuticals, Inc.CompletedOvarian CancerCanada, United States, United Kingdom